Nixon Peabody LLP

  • People
  • Capabilities
  • Insights
  • About

Trending Topics

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni

    Practices

    View All

    • Affordable Housing
    • Community Development Finance
    • Corporate & Finance
    • Cybersecurity & Privacy
    • Environmental
    • Franchising & Distribution
    • Government Investigations & White Collar Defense
    • Healthcare
    • Intellectual Property
    • International Services
    • Labor & Employment
    • Litigation
    • Private Wealth & Advisory
    • Project Finance
    • Public Finance
    • Real Estate
    • Regulatory & Government Relations

    Industries

    View All

    • Cannabis
    • Consumer
    • Energy
    • Entertainment
    • Financial Services
    • Healthcare
    • Higher Education
    • Infrastructure
    • Manufacturing
    • Non Profit
    • Real Estate
    • Technology

    Value-Added Services

    View All

    • Alternative Fee Arrangements

      Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.

    • Continuing Education

      Advancing professional knowledge and offering credits for attorneys, staff and other professionals.

    • Crisis Advisory

      Helping clients respond correctly when a crisis occurs.

    • DEI Strategic Services

      Providing our clients with legal, strategic, and practical advice to make transformational changes in their organizations.

    • eDiscovery

      Leveraging law and technology to deliver sound solutions.

    • Global Services

      Delivering seamless service through partnerships across the globe.

    • Innovation

      Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.

    • IPED

      Industry-leading conferences focused on affordable housing, tax credits, and more.

    • Legal Project Management

      Providing actionable information to support strategic decision-making.

    • Legally Green

      Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.

    • Nixon Peabody Trust Company

      Offering a range of investment management and fiduciary services.

    • NP Capital Connector

      Bringing together companies and investors for tomorrow’s new deals.

    • NP Second Opinion

      Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.

    • NP Trial

      Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.

    • Social Impact

      Creating positive impact in our communities through increasing equity, access, and opportunity.

    1. Home
    2. Insights
    3. Alerts
    4. OCR will not penalize covered healthcare providers and their vendors for HIPAA noncompliance at COVID-19 Community-Based Testing Sites (CBTSs) Alerts

    Alert / Health Care Alert

    OCR will not penalize covered healthcare providers and their vendors for HIPAA noncompliance at COVID-19 Community-Based Testing Sites (CBTSs)

    April 13, 2020

    Share

    By Valerie Montague

    This alert was co-authored by Meredith LaMaster. 

    OCR provides flexibility and best practices regarding data privacy and security related to the operation of CBTSs.

    On April 9, 2020, the U.S. Department of Health and Human Services, Office for Civil Rights (OCR) announced that it will exercise its enforcement discretion in its application of the Health Insurance Portability and Accountability Act’s (HIPAA’s) Privacy, Security, and Breach Notification Rules in relation to COVID-19 testing sites. OCR stated that penalties will not be imposed against covered healthcare providers or their business associate vendors for failure to comply with the HIPAA regulations related to operating a COVID-19 testing site. This exercise of enforcement discretion applies during the COVID-19 emergency only and is effective immediately, although it is retroactive to March 13, 2020.

    Because of the current nationwide public health emergency, numerous covered healthcare providers, including pharmacies, and their business associate vendors have opted to run mobile, drive-through, or walk-up COVID-19 specimen collecting and testing sites, commonly referred to as Community-Based Testing Sites, or CBTSs. The OCR enforcement discretion applies to both healthcare providers and their business associates in the good faith operations of a CBTS that offers COVID-19 testing or specimen collection to the public.

    Although it is exercising its discretion not to impose penalties, OCR encourages healthcare providers to take steps to safeguard the protected health information (PHI) of individuals being tested at CBTSs, including:

    • Using and disclosing the minimum necessary amount of PHI except when the PHI is being disclosed for treatment purposes.
    • Erecting canopies or other similar barriers and controlling foot and vehicle traffic at testing sites to provide both privacy and social distancing to individuals whose specimens are being collected.
    • Taking steps to prevent the media or the public from viewing, photographing, or filming individuals seeking testing, and posting signs that prohibit filming.
    • Using a secure network at the test site to record and transmit electronic PHI.
    • Placing a HIPAA Notice of Privacy Practices (NPP), or information about accessing one online, if necessary, in a location that is easily viewable by people approaching the CBTS.

    Although these safeguards are encouraged, covered healthcare providers and their business associates will not be penalized for HIPAA violations related to the good faith operation of a CBTS.

    It is important to note that the OCR enforcement discretion does not apply to health plans performing health plan functions. For example, if a HIPAA covered entity serves as both a plan and a healthcare provider, then the enforcement discretion only applies when the entity is acting in its healthcare provider capacity and is limited to activities involving CBTS operation. In addition, the enforcement discretion does not shelter healthcare providers or their business associates when the entities participate in non-CBTS–related tasks. As an example, OCR states that a pharmacy that runs a CBTS in its parking lot may still be penalized for HIPAA violations that take place inside the pharmacy and have no relation to the CBTS.

    Healthcare

    Practices

    HealthcareHealthcare TransactionsHealth Information - Privacy, Security, and Data Sharing

    Industries

    Healthcare

    Insights And Happenings

    • Alert

      COVID-19 Health Care Update: CMS Guidance on EMTALA

      March 19, 2020
    • Alert

      Updated following OCR limited waiver: To disclose or not to disclose: Sharing identifiable health information during the coronavirus outbreak

      March 18, 2020
    • Alert

      COVID-19 health care update: Considerations of medical practices and PE portfolio companies during the COVID-19 pandemic

      March 17, 2020

    Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • © 2023 Nixon Peabody. All rights reserved
    • Privacy Policy
    • Terms of Use
    • Statement of Client Rights
    • Supplier Diversity Program
    • Nixon Peabody International LLC
    • PAL